Skip to main content
VulnerabilityPublished

CVE-2026-129998: 1Panel-dev MaxKB · Eval Injection

Affects 1Panel-dev MaxKBSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 7.3 High : upgrade to 2.10.7-lts soon.

Data as of 20 Nov 2026, 20:13 UTC

CVSS 3.1 base score
7.3High
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (GitHub_M)CVSS 3.17.3
Patch
Available – fixed in 2.10.7-lts
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 20 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.

What to do

Upgrade 1Panel-dev MaxKB to 2.10.7-lts.

Affected software

ProductAffectedFixed in
1Panel-devMaxKBAffected
  • <2.10.7-lts
Fixed in
  • 2.10.7-lts

AI-suggested

Upgrade MaxKB to version 2.10.7-lts or later, where this eval injection vulnerability is fixed. No other mitigation is indicated by the vendor advisory.

Description

CVE-2026-129998 is an eval injection vulnerability in MaxKB, an open-source AI assistant for enterprise, affecting versions prior to 2.10.7-lts. Authenticated users with the default USER workspace role can inject JavaScript code via custom Tool Init Param definitions, which is then executed when the tool's Debug screen is opened. This allows script execution in the MaxKB origin, potentially exposing another user's bearer token and authenticated session if they render the malicious form. The vulnerability is fixed in version 2.10.7-lts.

References

Community reviews

Loading reviews…